PubRank

J Phair

Author PubWeight™ 99.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996 10.62
2 Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996 10.49
3 KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996 5.96
4 Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001 4.98
5 Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996 4.13
6 Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science 1998 3.86
7 Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987 3.58
8 Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 2000 3.20
9 A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998 3.15
10 A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 1990 2.89
11 HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol 1996 2.58
12 Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 1990 2.51
13 Effect of HCV, HIV and coinfection in kidney transplant recipients: mate kidney analyses. Am J Transplant 2014 2.22
14 Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr 2000 2.13
15 Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992 2.11
16 The multicenter AIDS Cohort Study, 1983 to …. Public Health 2011 1.93
17 Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr 1992 1.65
18 Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med 1993 1.58
19 Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med 1978 1.57
20 Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts. Am J Epidemiol 2001 1.55
21 Stressful life events and symptom onset in HIV infection. Am J Psychiatry 1991 1.50
22 Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest 1997 1.46
23 Outcomes of adult dual kidney transplants by KDRI in the United States. Am J Transplant 2013 1.41
24 A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team. J Acquir Immune Defic Syndr Hum Retrovirol 1998 1.28
25 HIV-related symptoms and psychological functioning in a cohort of homosexual men. Am J Psychiatry 1989 1.23
26 Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression. Am J Epidemiol 2002 1.11
27 Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. Am J Epidemiol 1995 1.01
28 The HLA-B/-C haplotype block contains major determinants for host control of HIV. Genes Immun 2009 1.00
29 Extended IL10 haplotypes and their association with HIV progression to AIDS. Genes Immun 2009 0.97
30 Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann Neurol 1988 0.94
31 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. AIDS 1991 0.93
32 Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. Am J Public Health 1990 0.92
33 Corticosteroid therapy in Epstein-Barr virus infection. Effect on lymphocyte class, subset, and response to early antigen. Arch Intern Med 1986 0.91
34 Decreased oxidative burst activity of monocytes from asymptomatic HIV-infected individuals. Clin Immunol Immunopathol 1990 0.90
35 Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l. AIDS 1995 0.88
36 Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis 1990 0.86
37 Psychosocial aspects of AIDS risk. Psychopharmacol Bull 1986 0.85
38 Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery. Vaccine 2008 0.85
39 Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection. J Clin Microbiol 1995 0.84
40 Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men. AIDS Res Hum Retroviruses 1990 0.82
41 Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression. AIDS Res Hum Retroviruses 1998 0.82
42 Two-dimensional echocardiographic features diagnostic of isolated pulmonic valve endocarditis. Am Heart J 1982 0.81
43 Thrush and fever as markers of immune competence in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2001 0.81
44 Isolation of HIV-1 from monocytes of individuals negative by conventional culture. J Infect Dis 1990 0.79
45 Polymorphonuclear leukocyte adherence to nylon: effect of oral corticosteroids. Infect Immun 1979 0.78
46 Relationship of hepatitis B virus infection to human immunodeficiency virus type 1 infection. J Infect Dis 1993 0.77
47 Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy. AIDS 2001 0.76
48 Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.76
49 AIDS onset at high CD4+ cell levels is associated with high HIV load. AIDS Res Hum Retroviruses 2000 0.76
50 A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients. AIDS 1990 0.75
51 Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study. Antivir Ther 1997 0.75
52 Malnutrition and hyperglycemia associated with TPN do not alter polymorphonuclear leukocyte adherence to nylon. JPEN J Parenter Enteral Nutr 1981 0.75
53 Therapy for acquired immunodeficiency syndrome. Implantation of cultured thymic fragments. Arch Intern Med 1986 0.75
54 The evaluation of selected parameters of immune function in asthmatics after long-term corticosteroid therapy. Clin Allergy 1979 0.75
55 Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix. Clin Infect Dis 2001 0.75
56 Chlamydia specific IgG and IgA serum antibodies in a study of homosexual men at various clinical stages of HIV related disease. In Vivo 1995 0.75
57 Cytomegalovirus IgG and IgA serum antibodies in a study of HIV infection and HIV related diseases in homosexual men. J Med Virol 1991 0.75
58 HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection. J Hum Virol 2002 0.75